Dr. Olivia Telle Van Gerwen, MD

  • Birmingham, AL
  • Infectious disease specialist
NPI1487072393PAC ID1254626609
Medicare services, 2024
101
Medicare patients, 2024
61
Part D claims, 2024
841
Publications
35
Hospital affiliations
1
Practice address
619 19th S St, Birmingham, AL 35211
Practice phone
Call (205) 731-9770
Professional email
Get professional email
Personal email
Get personal email
Mobile number
Get mobile number
Social profiles

Primary practice

University of Alabama Birmingham Hospital

Birmingham, Alabama

See all 7 affiliations

Find Dr. Van Gerwen's professional email, personal email and mobile number

Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.

View contacts for free

Dr. Olivia Telle Van Gerwen is an infectious disease specialist in Birmingham, Alabama

Dr. Van Gerwen practices at University of Alabama Birmingham Hospital in Birmingham, Alabama.

Dr. Van Gerwen's NPI, 1487072393, was assigned on March 29, 2014. Dr. Van Gerwen graduated from University of Alabama School of Medicine in 2014. Dr. Van Gerwen holds Alabama license 36962.

NPI and contact details
Medicare PAC ID
1254626609
NPI enumeration date
March 29, 2014
NPI status
Active
Accepts Medicare assignment
Yes
Practice phone
(205) 731-9770
Professional email
Get email
Personal email
Get email
Mobile number
Get number
Sex
Female
Estimated age
38
Medical school graduation
2014

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Practice Data; and Doctors and Clinicians National Downloadable File (CMS)

Dr. Olivia Telle Van Gerwen practices at University of Alabama Birmingham Hospital in Birmingham, Alabama

Dr. Van Gerwen's primary practice is University of Alabama Birmingham Hospital, at 619 19th S St, Birmingham, AL 35211 in Jefferson County. The practice phone is (205) 731-9770.

  • University of Alabama Birmingham Hospital
    619 19th S St, Birmingham, AL 35211 · Jefferson CountyPhone(205) 731-9770

Sources: NPPES NPI Registry (CMS); and Dmand AI Practice Data

Dr. Olivia Telle Van Gerwen is affiliated with 3 sites of care and 4 medical groups

Dr. Van Gerwen's primary practice is University of Alabama Birmingham Hospital in Birmingham, Alabama. Dr. Van Gerwen is also affiliated with UAB Hospital. The medical group on file is UAB Medicine. Dmand AI also links Dr. Van Gerwen to 3 more medical groups and 1 group practice or clinic, each named with a free account.

See all 7 affiliations for Dr. Van Gerwen

Sources: NPPES NPI Registry (CMS); Dmand AI Practice Data; and Dmand AI Affiliation Data

Dmand AI tracks the EHR system at Dr. Olivia Telle Van Gerwen's practice

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Van Gerwen practices, 2 sites in all. Vendor and product names are available with a free account.

EHR by site
SiteEHR vendor and product
University of Alabama Birmingham HospitalAvailable with a free account
+2 more sites and 3 medical groupsAvailable with a free account

Source: Dmand AI Technology Install Data

For health IT teams

See the EHR and IT leaders at every site where Dr. Van Gerwen practices

Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.

Dr. Olivia Telle Van Gerwen is one of 103 infectious disease specialists in Alabama

Infectious disease is Dr. Van Gerwen's primary specialty in the NPI Registry, under taxonomy code 207RI0200X. Dr. Van Gerwen is licensed in Alabama.

Specialties and state licenses

  • Infectious disease, AlabamaPrimaryLicense 36962 · taxonomy 207RI0200X

Infectious disease specialists near Dr. Van Gerwen

Counts of infectious disease specialists with a Dmand AI profile, by place and practice. Each opens the list.

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks

Dr. Olivia Telle Van Gerwen billed Medicare for 101 services in 2024

CMS data shows 101 Medicare services from Dr. Van Gerwen across 5 procedure codes in 2024, for 61 Medicare patients. Medicare paid $6,216 for them.

Medicare services, 2024101
Medicare patients61
Paid by Medicare$6,216
Procedure codes5

Dr. Van Gerwen's Medicare services by type, 2023 to 2024

  • 2023
  • 2024
Office and hospital visits
2023: 552024: 7231%
Other services
2023: 02024: 29

Where Dr. Van Gerwen's Medicare services took place, 2024

  • In an office6160%
  • In a facility4040%

Dr. Van Gerwen compared with the Alabama median for infectious disease specialists, 2024

  • Dr. Van Gerwen
  • Alabama median
Medicare services
101vs 16740% below
Medicare patients
61vs 9938% below
Part D claims
569vs 2062.8 times

Medians across 103 infectious disease specialists in Alabama with Dmand AI profiles that report each measure.

Dr. Van Gerwen's most billed Medicare procedure codes, 2024

CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.

See all procedures by Dr. Van Gerwen

Need commercial claims for Dr. Van Gerwen?

Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Van Gerwen and other infectious disease specialists in Alabama.

Book a meeting

Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks

Dr. Olivia Telle Van Gerwen treated 61 Medicare patients in 2024, average age 61

CMS counts 61 Medicare patients who saw Dr. Van Gerwen in 2024. The largest group is under 65, with 34 patients. 75% of them have high blood pressure, and 74% have high cholesterol. 48% are also on Medicaid. Their average risk score is 2.38, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Van Gerwen's median patient age at 35, with 46% women.

Medicare patients, 202461
Average age61
Average risk score2.38
Also on Medicaid48%

Dr. Van Gerwen's Medicare patients by age, 2024

CMS leaves out age groups with fewer than 11 patients.

Dr. Van Gerwen's Medicare patients by sex, 2024

  • Women2236%
  • Men3964%

Chronic conditions among Dr. Van Gerwen's Medicare patients, 2024

  1. High blood pressure75%
  2. High cholesterol74%
  3. Arthritis51%
  4. Diabetes49%
  5. Chronic kidney disease46%
  6. Mood disorders44%
  7. Anxiety39%
  8. Depression38%

Share of Medicare patients with each condition. A patient can have several.

Dr. Van Gerwen's patients across all payers

Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.

Patient panel by age, all payers

Median age 35

Patient panel by sex, all payers

  • Women46%
  • Men54%

Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data

Dr. Olivia Telle Van Gerwen wrote 841 Medicare Part D claims in 2024

In 2024, Dr. Van Gerwen wrote 841 Medicare Part D claims for 72 patients. 80% of them were for generic drugs. CMS names the drug for 569 of them, across 29 drugs with 11 or more claims each, at $400,407 in total drug cost. In 2023, CMS named 778 claims across 28 drugs.

Part D claims, 2024841
Drugs named by CMS29
Total drug cost$400,407
Part D patients72

Dr. Van Gerwen's Part D claims by kind of drug, 2024

  • Generic670 claims80%
  • Brand-name159 claims19%
  • Other12 claims1%

Dr. Van Gerwen's most prescribed drugs by claims, 2024

CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.

Drug classes CMS tracks in Dr. Van Gerwen's Part D claims, 2024

  • Opioids1%12 of 841 claims
  • Antibiotics7%57 of 841 claims

Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.

Part D claims for drugs CMS names, 2023 to 2024

  • 2023
  • 2024
Claims for drugs CMS names
2023: 7782024: 56927%

Drugs named by CMS: 29 in 2024, 28 in 2023.

See all prescribing by Dr. Van Gerwen

Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data

How Dr. Olivia Telle Van Gerwen takes part in Medicare

Dr. Van Gerwen accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Accepts Medicare assignment
Yes

Source: Doctors and Clinicians National Downloadable File (CMS)

For MedTech and pharma teams

Find infectious disease specialists like Dr. Van Gerwen by procedure volume and prescribing

Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.

Dr. Olivia Telle Van Gerwen has 35 publications on record

Dmand AI links 35 papers to Dr. Van Gerwen, published from 2019 to 2025. 2024 was the busiest year, with 7. The most frequent topics are HIV Infections, Transgender Persons and Trichomonas Infections. Dr. Van Gerwen has published most often in Sex Transm Dis. Dr. Van Gerwen's most frequent co-authors are Christina A. Muzny, Krishmita Siwakoti and Nicholas J. Van Wagoner.

Papers35
Years published2019 to 2025

Dr. Van Gerwen's papers by year, 2019 to 2025

Topics Dr. Van Gerwen writes about most

  • HIV Infections
  • Transgender Persons
  • Trichomonas Infections
  • Trichomonas vaginalis
  • Vaginosis, Bacterial
  • Sexually Transmitted Diseases
  • Trichomonas Vaginitis
  • Metronidazole

Dr. Van Gerwen's most frequent co-authors

Recent publications by Dr. Van Gerwen

See all 35 publications and co-authors

See who Dr. Van Gerwen researches with

Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Van Gerwen works with, so you can find a warm path to the right infectious disease specialists.

How network discovery works

Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage

Dr. Olivia Telle Van Gerwen received $9,890 in industry payments from 2022 to 2025

CMS Open Payments shows 9 general payments to Dr. Van Gerwen from 5 drug and device companies from 2022 to 2025. Consulting fees make up the largest share, 79% of the total. bioMerieux paid the most, $8,382.

General payments to Dr. Van Gerwen by program year, 2022 to 2025

General payments to Dr. Van Gerwen by kind, 2022 to 2025

$9.9Kin total
  • Consulting fees$7,85379%
  • Travel and lodging$1,66917%
  • Food and beverage$3694%

Companies that paid Dr. Van Gerwen the most, 2022 to 2025

Share is of all general payments to this clinician.

See all payments to Dr. Van Gerwen

Source: Open Payments (CMS), 2025 data, released July 7, 2026

Dr. Olivia Telle Van Gerwen graduated from University of Alabama School of Medicine

Dr. Van Gerwen graduated from University of Alabama School of Medicine in 2014.

  1. Medical schoolUniversity of Alabama School of Medicine

Source: Dmand AI Professional Profile Data

Sources for Dr. Olivia Telle Van Gerwen's profile data

Sources for the data on this page
Data on this pageSource
NPI, name, sex, specialty and licensesNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data
Practice locations and phoneNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice Data
Primary practice, affiliations and health systemNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice DataDmand AI Affiliation Data
Medicare services and procedure codesMedicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab)
State medians for the same specialtyDmand AI Peer Benchmarks
Medicare patients and the all-payer patient panelDmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab)
Part D prescribingMedicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab)
MIPS scores, telehealth, assignment and procedure percentilesDoctors and Clinicians National Downloadable File (CMS) (opens in a new tab)
Publications, topics and co-authorsPubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage
Industry paymentsOpen Payments (CMS) (opens in a new tab)
Training, board certification and membershipsDmand AI Professional Profile Data
EHR at each practice siteDmand AI Technology Install Data
Similar physiciansDmand AI Affiliation Data

Data last refreshed October 2026Report an inaccuracyRemove my information

FAQ

Frequently asked questions about Dr. Olivia Telle Van Gerwen

Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.

What is Dr. Olivia Telle Van Gerwen's NPI number?

Dr. Olivia Telle Van Gerwen's NPI number is 1487072393. It was assigned on March 29, 2014, and it is active in the NPI Registry.

What kind of doctor is Dr. Olivia Telle Van Gerwen?

Dr. Olivia Telle Van Gerwen is an infectious disease specialist in Birmingham, Alabama. The primary specialty in the NPI Registry is Infectious Disease Physician (taxonomy code 207RI0200X).

Where does Dr. Olivia Telle Van Gerwen practice?

Dr. Van Gerwen practices at 619 19th S St, Birmingham, AL 35211. Dr. Van Gerwen's primary practice is University of Alabama Birmingham Hospital in Birmingham, Alabama. Dmand AI also links Dr. Van Gerwen to 3 medical groups and 1 group practice or clinic.

What is Dr. Olivia Telle Van Gerwen's office phone number?

The practice phone on file for Dr. Van Gerwen is (205) 731-9770.

What is Dr. Olivia Telle Van Gerwen's medical license number?

Dr. Van Gerwen holds Alabama license 36962.

Which hospitals is Dr. Olivia Telle Van Gerwen affiliated with?

Dr. Van Gerwen is affiliated with UAB Hospital.

What medical group is Dr. Olivia Telle Van Gerwen part of?

Dr. Van Gerwen is linked to UAB Medicine. Dmand AI links Dr. Van Gerwen to 3 more medical groups.

Does Dr. Olivia Telle Van Gerwen accept Medicare?

Yes. CMS data shows Dr. Van Gerwen billed Medicare for 101 services in 2024, and Dr. Van Gerwen accepts Medicare assignment.

How many Medicare patients does Dr. Olivia Telle Van Gerwen see?

CMS counts 61 Medicare patients who saw Dr. Van Gerwen in 2024, with an average age of 61.

What services does Dr. Olivia Telle Van Gerwen bill to Medicare?

In 2024, Dr. Van Gerwen's most billed Medicare services were office visit, established patient (99214), medicare service (G2211) and hospital inpatient care (99232).

Show 6 more questionsShow fewer questions

Where did Dr. Olivia Telle Van Gerwen go to medical school?

Dr. Van Gerwen graduated from University of Alabama School of Medicine in 2014.

What drugs does Dr. Olivia Telle Van Gerwen prescribe most?

In 2024 Medicare Part D data, Dr. Van Gerwen's most prescribed drugs by claims were Atorvastatin Calcium, Biktarvy and Gabapentin.

Has Dr. Olivia Telle Van Gerwen received payments from drug or device companies?

CMS Open Payments shows $9,890 in general payments to Dr. Van Gerwen from 5 companies from 2022 to 2025. The largest total came from bioMerieux.

How long has Dr. Olivia Telle Van Gerwen been practicing?

Dr. Van Gerwen graduated from medical school in 2014, 12 years ago.

Does Dr. Olivia Telle Van Gerwen do research?

Dmand AI links 35 publications to Dr. Van Gerwen, published from 2019 to 2025.

Who does Dr. Olivia Telle Van Gerwen publish with?

Dr. Van Gerwen's most frequent co-authors are Christina A. Muzny (27 shared papers), Krishmita Siwakoti (4 shared papers) and Nicholas J. Van Wagoner (3 shared papers).

Selling to infectious disease practices?

See infectious disease specialists in Alabama by site of care and group

Find the practices, groups and hospitals they work with, and the right people to contact at each.

  • 30 days free
  • Self-serve
  • No credit card

Cookie settings

Turn each category on or off. Your choice is kept for 12 months and you can change it here at any time.

Necessary

Always on. Sign-in, security, downloads you asked for, your cookie choice, and the page that led to a signup.

View cookies (6)
  • dm_consentDmand AI. Your cookie choices and whether your browser sent a Global Privacy Control signal. 12 months.
  • dm_ft, dm_ltDmand AI. The first and the latest page you arrived on, with the date, so a signup is credited to the page that worked. 90 days, 30 days.
  • dm_fs, dm_lsDmand AI. The first and the latest source of a visit (a search engine, a campaign or the site that linked here). 90 days, 30 days.
  • dm_dl, dm_dl_okDmand AI. After you give an email address for a download, lets you download files without being asked again. 30 days.
  • Session and CSRF cookiesDmand AI (app.dmand.ai). Sign-in and form protection in the application. Session.
  • __cf_bm, cf_clearanceCloudflare. Tells people from automated traffic and keeps the site available. 30 minutes; cf_clearance while a security check is valid.

Analytics

On unless you turn it off. How pages are used, in aggregate, and recordings of how pages are used.

View cookies (6)
  • Google Tag ManagerGoogle. Loads the analytics and marketing tags that are on. Sets no cookie of its own and does not load when both categories are off. n/a.
  • _ga, _ga_<container-id>Google Analytics 4. Visits and page views in aggregate on dmand.ai. 2 years.
  • _clck, _clskMicrosoft Clarity. Recordings and heatmaps of how pages are used, with form fields masked. 1 year, 1 day.
  • CLID, MUID, ANONCHK, MR, SMMicrosoft (clarity.ms). Set by Microsoft when Clarity loads, to recognize a browser across sites that use Clarity. Up to 1 year.
  • None (cookieless)Ahrefs Analytics. Page views in aggregate. n/a.
  • ph_<project>_posthogPostHog. Product usage, errors and performance in app.dmand.ai, used to fix bugs and improve features. 365 days.

Marketing

On unless you turn it off, and always off when your browser sends a Global Privacy Control signal. A visitor identification service tells our sales team which companies and people visit.

View cookies (6)
  • _reb2buid, _reb2butkRB2B. Recognizes a returning browser for visitor identification. 360 days, 1 year.
  • _reb2bgeoRB2B. The location used to decide whether a visit can be identified. 20 days.
  • _reb2brefRB2B. The page or site that referred the visit. 15 days.
  • _reb2bfxf, _reb2btd, _reb2bliRB2B. Links the visit to an identified business profile. 1 month.
  • _reb2bresolveRB2B. Holds a match while it is being resolved. 2 days.
  • _reb2sessionID, _reb2bloadedRB2B. The current visit, and a guard against loading the script twice. 30 minutes, 1 second.

Functional

On unless you turn it off. Remembers choices such as a collapsed section.

View cookies (none today)